- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Pharmaceutical company funding and its consequences: A qualitative systematic review
Abstract
This article systematically reviews published studies of the association of pharmaceutical industry funding and clinical trial results, as well a few closely related studies. It reviews two earlier results, and surveys the recent literature. Results are clear: Pharmaceutical company sponsorship is strongly associated with results that favor the sponsors' interests.Author's Profile
Links
PhilArchive
External links
(no proxy)
Setup an account with your affiliations in order to access resources via your University's proxy server
Through your library
- Only published works are available at libraries.
My notes
Similar books and articles
Researcher Views About Funding Sources and Conflicts of Interest in Nanotechnology.Katherine A. McComas - 2012 - Science and Engineering Ethics 18 (4):699-717.
Pharmaceutical medicine.D. M. Burley & Theodore Barker Binns (eds.) - 1985 - Baltimore, Md., U.S.A.: E. Arnold.
Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry?Sergio Sismondo - manuscript
Commercialism and Universities: An Ethical Analysis. [REVIEW]Richard Carter - 2010 - Journal of Academic Ethics 8 (1):1-19.
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW]Joel Lexchin - 2012 - Science and Engineering Ethics 18 (2):247-261.
Understanding physician-pharmaceutical industry interactions.Shaili Jain - 2007 - New York: Cambridge University Press.
Pharmaceutical Company Gifts: From Voluntary Standards to Legal Demands.Rebecca Dresser - 2006 - Hastings Center Report 36 (3):8-9.
Conflicts of interest in drug development: The practices of merck & co., inc.Laurence J. Hirsch - 2002 - Science and Engineering Ethics 8 (3):429-442.
Analytics
Added to PP
2009-01-28
Downloads
40 (#387,619)
6 months
3 (#1,023,809)
2009-01-28
Downloads
40 (#387,619)
6 months
3 (#1,023,809)
Historical graph of downloads
Author's Profile
Citations of this work
It Takes a Village to Trust Science: Towards a (Thoroughly) Social Approach to Public Trust in Science.Gabriele Contessa - 2023 - Erkenntnis 88 (7):2941-2966.
Feyerabend and manufactured disagreement: reflections on expertise, consensus, and science policy.Jamie Shaw - 2020 - Synthese 198 (Suppl 25):6053-6084.
Ensuring the Quality, Fairness, and Integrity of Journal Peer Review: A Possible Role of Editors.David B. Resnik & Susan A. Elmore - 2016 - Science and Engineering Ethics 22 (1):169-188.
Financial Conflicts of Interest and Criteria for Research Credibility.Kevin C. Elliott - 2014 - Erkenntnis 79 (S5):917-937.
Institutional Conflicts of Interest in Academic Research.David B. Resnik - 2015 - Science and Engineering Ethics 25 (6):1661-1669.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-4c2ch uwo